This invention is an intraoral palate expanding plate with an expansion screw for both cleft palate and restricted airways that can be produced by 3-D printing and CT scans.
Researchers at Stanford have found that nascent polypeptide-associated complex (NAC) and the apical domain of CCT1, as well as peptide fragments and fusion proteins containing them, can be used to suppress pathological protein aggregation.
Stanford inventor Dr. Anne Liu has developed an algorithm that can assess the risk of allergic reaction to antibiotics and help clinicians make decisions about which antibiotic to prescribe in patients who have a history of antibiotic allergies at the point-of-care.
Researchers at Stanford University have developed a deep learning software algorithm that allows physicians running clinical trials to predict control patient outcomes using virtual control arms.
Jennifer Cochran and Carolyn Bertozzi have collaborated to develop a bifunctional molecule called a polyspecific integrin-binding peptide (PIP)-LYTAC that can bind to integrins expressed on the surface of cancer cells and trigger their degradation via the lysosome.
As of 2020, radiation therapy has saved over 3.38 million cancer patients in the US. Radiation therapy treatment planning often involves a time-consuming and labor-intensive process where physicians must manually optimize the prescribed radiation dose.
A Stanford University physician has developed a device to stimulate regeneration of olfactory nerves using minimally invasive electrical neurostimulation.
Scientists at the Stanford Autism Center have invented a questionnaire called the Stanford Social Dimensions Scale (SSDS) for measuring key social processes including social motivation, social communication and social recognition in both the general population and a wide range
This invention involved a new methodology using novel targets, TMS stimulation and a hypnosis protocol to modulate traits and help chronic pain, addiction, and mental disorders.
Stanford researchers have applied large-scale proteomic platforms to identify biomarkers that can be used to diagnose uveal melanoma and subtype eye tumors according to their gene expression profile (GEP) class or PRAME status.
Researchers in the Felsher Lab at Stanford University have developed PD-L1 antibody fragment-conjugated nanoparticles to improve upon existing cancer immunotherapies and extend the range of indications to solid tumors.
A team of researchers at Stanford have developed a hydrogel that delivers a scar-reducing focal adhesion kinase inhibitor (FAK-I) to skin grafts and donor sites.
Psoriasis is a chronic skin inflammatory disease that affects 7.5 million people in the US and accounts for $1.2 billion in annual direct medical costs.